Diving Into US FDA’s Newly Public CRLs

 
• By Bridget Silverman
  
The FDA's unprecedented publication of some complete response letters for unapproved applications provided a wealth of information. (Shutterstock)

More from Complete Response Letters

More from Product Reviews